Marina Macchini

2.5k total citations
52 papers, 420 citations indexed

About

Marina Macchini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Marina Macchini has authored 52 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Marina Macchini's work include Pancreatic and Hepatic Oncology Research (34 papers), Cancer Genomics and Diagnostics (18 papers) and Renal cell carcinoma treatment (11 papers). Marina Macchini is often cited by papers focused on Pancreatic and Hepatic Oncology Research (34 papers), Cancer Genomics and Diagnostics (18 papers) and Renal cell carcinoma treatment (11 papers). Marina Macchini collaborates with scholars based in Italy, Spain and United States. Marina Macchini's co-authors include Michele Reni, Umberto Peretti, Silvia Zanon, Luca Gianni, Massimo Falconi, Marta Chiaravalli, Elena Mazza, Paolo Giorgio Arcidiacono, Gianpaolo Balzano and Guido Biasco and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Marina Macchini

47 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marina Macchini Italy 11 295 137 130 117 85 52 420
Gustavo Schvartsman Brazil 11 370 1.3× 201 1.5× 118 0.9× 42 0.4× 101 1.2× 31 488
Yosuke Tsuruga Japan 13 168 0.6× 130 0.9× 225 1.7× 62 0.5× 111 1.3× 43 516
Cinzia Baldessari Italy 13 292 1.0× 207 1.5× 107 0.8× 50 0.4× 102 1.2× 43 464
Joanna Huszno Poland 11 193 0.7× 146 1.1× 61 0.5× 102 0.9× 131 1.5× 37 425
Shinsuke Kanekiyo Japan 15 250 0.8× 113 0.8× 138 1.1× 144 1.2× 163 1.9× 45 530
Angelika Terbuch Austria 13 172 0.6× 159 1.2× 120 0.9× 103 0.9× 149 1.8× 33 397
Marta Chiaravalli Italy 9 484 1.6× 219 1.6× 136 1.0× 224 1.9× 81 1.0× 19 554
Urbano Anido Spain 13 359 1.2× 252 1.8× 120 0.9× 172 1.5× 133 1.6× 67 584
Hidekazu Hirano Japan 12 368 1.2× 225 1.6× 158 1.2× 74 0.6× 141 1.7× 91 586
Rania Chehade Canada 8 327 1.1× 174 1.3× 79 0.6× 58 0.5× 125 1.5× 21 485

Countries citing papers authored by Marina Macchini

Since Specialization
Citations

This map shows the geographic impact of Marina Macchini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Macchini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Macchini more than expected).

Fields of papers citing papers by Marina Macchini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Macchini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Macchini. The network helps show where Marina Macchini may publish in the future.

Co-authorship network of co-authors of Marina Macchini

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Macchini. A scholar is included among the top collaborators of Marina Macchini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Macchini. Marina Macchini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Reni, Michele, Guido Giordano, Marina Macchini, et al.. (2024). Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life. Digestive and Liver Disease. 57(1). 104–110.
4.
Pecorelli, Nicolò, Lívia Archibugi, Marina Macchini, et al.. (2024). Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis. Pancreatology. 24(3). 437–444. 2 indexed citations
6.
Vanella, Giuseppe, Giuseppe Dell’Anna, Gabriele Capurso, et al.. (2023). EUS-guided gastroenterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting. Gastrointestinal Endoscopy. 98(3). 337–347.e5. 39 indexed citations
7.
Petrelli, Fausto, Michele Ghidini, Marina Macchini, et al.. (2023). The Role of Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer: A Network Meta-Analysis. Journal of Gastrointestinal Cancer. 54(4). 1376–1379. 1 indexed citations
8.
Gasparini, Giulia, Francesca Aleotti, Giulio Belfiori, et al.. (2023). The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma. Digestive and Liver Disease. 55(12). 1750–1756. 4 indexed citations
9.
Grassini, Greta, Lorenza Pecciarini, Marco Schiavo Lena, et al.. (2022). Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples. Clinical Gastroenterology and Hepatology. 21(11). 2825–2833. 9 indexed citations
10.
Milella, Michèle, Claudio Bassi, Ugo Boggi, et al.. (2021). Evolving pancreatic cancer treatment: From diagnosis to healthcare management. Critical Reviews in Oncology/Hematology. 169. 103571–103571. 14 indexed citations
11.
Macchini, Marina, Umberto Peretti, Giulia Orsi, et al.. (2020). Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients. Cancer Chemotherapy and Pharmacology. 87(1). 95–101. 2 indexed citations
12.
Reni, Michele, Valentina Andreasi, Anna Maria Gasparri, et al.. (2020). Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 10. 613582–613582. 1 indexed citations
13.
Reni, Michele, Umberto Peretti, Silvia Zanon, et al.. (2020). Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma. Cancer Chemotherapy and Pharmacology. 85(4). 641–650. 9 indexed citations
14.
Macchini, Marina, Marta Chiaravalli, Chiara Pircher, et al.. (2020). Multidrug regimens for treatment of older patients with metastatic pancreatic cancer. Digestive and Liver Disease. 53(1). 117–121. 1 indexed citations
15.
Reni, Michele, Silvia Zanon, Umberto Peretti, et al.. (2018). Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial. ˜The œLancet. Gastroenterology & hepatology. 3(10). 691–697. 54 indexed citations
16.
Zanon, Silvia, Chiara Pircher, Marina Macchini, et al.. (2017). Randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (paxg regimen) in metastatic pancreatic adenocarcinoma. Annals of Oncology. 28. vi44–vi45. 1 indexed citations
17.
Marco, Mariacristina Di, et al.. (2016). Retroperitoneal lymphangioma: A report of 2 cases and a review of the literature regarding the differential diagnoses of retroperitoneal cystic masses. Oncology Letters. 11(5). 3161–3166. 16 indexed citations
18.
Brandi, Giovanni, Simona Tavolari, Tiziana Guarnieri, et al.. (2013). Antiprotease Strategy in Pancreatic Cancer Treatment. Pancreas. 43(1). 53–63. 3 indexed citations
19.
Marco, Mariacristina Di, Marina Macchini, Riccardo Casadei, et al.. (2011). Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer: A literature review and report of two cases. Oncology Letters. 2(2). 195–200. 1 indexed citations
20.
Nobili, Elisabetta, Roberto Di Cicilia, Monica Di Battista, et al.. (2010). Venous Thromboembolism and Port-Related Thrombosis in Metastatic Colorectal Cancer Patients: A Monocenter Experience. Pathophysiology of Haemostasis and Thrombosis. 37(1). 30–34. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026